THE Therapeutic Goods Administration (TGA) has been designated as an 'Authority' by the World Heath Organization, strengthening the Australian body's access to medicines.
WHO Listed Authority (WLA) organisations are identified as national regulatory bodies that demonstrate advanced regulatory capability.
The TGA joins a select group of high-performing regulators, including the European Medicines Agency and Health Canada who are globally acknowledged for meeting international benchmarks.
"The WLA designation is a significant milestone for Australia, clearly demonstrating our commitment to regulatory excellence and public health," said Anthony Lawler, head of the TGA.
"It is a testament to the dedication and expertise of our organisation and people."
Lawler highlighted the importance of this designation in an era of widespread misinformation and disinformation circulating the medicinal community.
"This important recognition from the WHO reinforces that the TGA's decisions are evidence-based.
"Australians can trust in using the medicines and vaccines approved by the TGA.
"WLA regulators also play a critical role in improving global health by enabling others to rely on and have trust in the decisions we make."
The designation builds on the TGA's legacy as a previously recognised Stringent Regulatory Authority, which has been replaced by the WLA.
This new initiative was introduced in 2022, with many national bodies rolling over.
The above article was sent to subscribers in Pharmacy Daily's issue from 06 Jan 26
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 06 Jan 26
